Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV).

Mohamed Bouchahda,Denis Castaing,Céline Lepère,Rosine Guimbaud,Mohamed Hebbar,Philippe Rougier,Salvatore Tumolo,Michel Ducreux,Pasquale F Innominato,Sameh Awad,Thierry De Baère ,J F Morère ,C Focan ,Stéphanie Truant ,Carlos Carvalho ,Abdoulaye Karabouã ,Denis Smith ,Valérie Boige ,Julien Taı̈eb ,Françis Lévi

doi:10.1200/jco.2016.34.15_suppl.e15036

Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV).

Mohamed Bouchahda, Denis Castaing + Show 18 more

https://doi.org/10.1200/jco.2016.34.15_suppl.e15036

Copy DOI

Export

Save

Cite

Journal: Journal of Clinical Oncology

Publication Date: May 20, 2016

Affiliation: Hôpital Paul-Brousse, Inserm, Assistance Publique – Hôpitaux de Paris, Hôpital Européen, Hôpital Européen Georges-Pompidou, Hôpital Rangueil, Lesaffre (France), Institut Gustave Roussy, University of Warwick, Clinique Saint-Joseph, Centre Hospitalier Chrétien, Centre Hospitalier Universitaire de Lille, Hospital Prof. Dr. Fernando Fonseca, Hôpital Saint-André

#Failure Of Systemic Chemotherapy #Early Tumor Shrinkage #Intravenous Cetuximab #Unresectable Liver Metastases #Long-term Outcome In Patients #Early Tumor #Infusion Of Oxaliplatin #Outcome In Patients #Infusion Of 5-fluorouracil #Failure Of Chemotherapy

Abstract
Full-Text
Similar Papers

Abstract

Listen

e15036Background: Early tumor shrinkage has been associated with improved long-term outcome in patients (pts) with chemotherapy (chemo)-refractory LM-CRC. We examined the prognostic relevance of ea...

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime